Search Results for "amyloid Alzheimer's"
Some journalists fire another “silver bullet” at Alzheimer’s amyloid target
The following is a guest blog post from one of our regular contributors, Alan Cassels, who is an author, journalist, and drug policy researcher with an interest in how clinical research and experience on pharmaceuticals gets translated for policy-makers, prescribers and consumers. ————————– A March 20th story in the Boston Globe. “Biogen drug offers hope for […]8/7/2012
Amyloid & Alzheimer’s: the cause-and-effect question that some stories still miss
The announcement by Johnson & Johnson and Pfizer that they were pulling the plug on clinical testing of the Alzheimer’s drug Bapineuzumab after two failed clinical trials, got a lot of mainstream news media coverage – as it should have to balance some of the earlier breathless hype about the drug’s potential. But not many […]
What you need to know about the Alzheimer’s test news
For years, substances called tau protein or beta-amyloid have been theorized to be signs or causes of Alzheimer’s disease. There have been many reports of tests and treatments based on theories that tau and/or amyloid are at least signs, if not causes, of Alzheimer’s. Scientific uncertainty remains about the precise role of tau and amyloid […]
USA Today provides rosy speculation about an Alzheimer’s vaccine not yet tested in humans
The story played up wishful conjecture about slashing dementia cases in half.
Researcher: Alzheimer's vaccine could cut dementia in half, human trials may be next
What you need to know about yet another study on Alzheimer’s and exercise
Including “exercise” and “Alzheimer’s” in the same headline is sure-fire clickbait for a lot of people. For example: 150 minutes of exercise every week can reduce risk of Alzheimer’s disease (The Economic Times) Exercise may delay rare form of Alzheimer’s (HealthDay) But these headlines refer to a study published earlier this week that doesn’t justify such […]3
How the ‘optimism’ narrative in Alzheimer’s helps the drug industry and harms patients
When I think about what will be lost when HealthNewsReview.org closes its doors at the end of 2018, our emphasis on independent expert assessment of health care claims looms as one of the biggest deficits. We’ve pointed out time and again how health care news can be tainted by the influence of industry and hidden […]1
Many questions linger about this possible Alzheimer’s treatment. So why the avalanche of news coverage?
News organizations rightly reported the numerous asterisks attached to a small mid-stage study of a potential Alzheimer’s treatment highlighted at this week’s Alzheimer’s Association International Conference. As some stories reported, the study was a Phase 2 trial that hasn’t been peer reviewed or published in a journal, in which the drug didn’t meet its primary […]
Diagnosing Alzheimer’s using biomarkers–AP makes it clear that there is no benefit to patients
Still, we would have liked to see comment from an independent source on how this news might be misconstrued, especially by readers worried about their own risk for developing the disease.
New way of defining Alzheimer's aims to find disease sooner
‘Daily ibuprofen can prevent Alzheimer’s disease’ and other unproven claims by Canadian neuroscientist
The news release suggests that the way to diagnose Alzheimer’s disease early is by looking for elevated levels of Abeta42 in the saliva, thereby allowing early treatment with ibuprofen. However, no data on the accuracy of this screening method is included.
Canadian neuroscientists say daily ibuprofen can prevent Alzheimer's disease
‘$7.9 trillion’ savings from earlier Alzheimer’s diagnosis: Is there a hidden agenda behind the numbers?
More disease advocacy organizations are enlisting business consulting groups to conduct research to further their causes and, not coincidentally, those of their pharmaceutical company sponsors. This week the strategy paid off for the Alzheimer’s Association: An article in Bloomberg News headlined “Spotting Alzheimer’s Early Could Save America $7.9 Trillion” came from the annual Facts and […]
Daytime sleepiness and Alzheimer’s risk: What you need to know
Older adults who reported excessive daytime sleepiness were also more likely to have increasing levels of a protein called beta-amyloid in their brains over time, according to a study in JAMA Neurology. Beta amyloid deposits are one of several pathologic signs of Alzheimer’s disease. It’s an intriguing finding, and one that adds to a body […]
ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s
This story buoyantly reports on a finding that amyloid plaque can be reversed in mice but misses potential harms and an announcement about an aborted BACE1 trial in humans just a day earlier.
Alzheimer's disease reversed in mice, offering hope for humans, new research shows
Retinal imaging detects biomarker for Alzheimer’s: Novel yes, but practical?
Great descriptions on a novel test needed more data to buoy diagnostic claims.
Clinical study shows that retinal imaging may detect signs of Alzheimer's disease
5 questions to ask when writing (and reading) about new Alzheimer’s drug research
Now is a good time to prepare for the onslaught of public relations messages about new Alzheimer’s disease (AD) drugs that are coming down the pike. This fall, at least six phase III AD drug trials will be wrapping up–and it’s a sure bet their findings will be published in both major and minor journals […]
Here’s why you can go ahead and ignore all those clickbaiting ‘olive oil protects against Alzheimer’s’ headlines
What a story from USA Today: “Extra virgin olive oil staves off Alzheimer’s, preserves memory, new study shows.” I’m not even sure where to begin on this one. So. Many. Issues. And, unfortunately, USA Today was not the only news outlet to cover this study. Newsweek, the Atlanta Journal-Constitution, and Philadelphia Inquirer all covered it, too. […]